Impact of antenatal corticosteroid exposure on thymus size in premature infants

dc.contributor.authorKilicdag, Hasan
dc.contributor.authorTorer, Birgin
dc.contributor.authorDemir, Senay
dc.contributor.authorHanta, Deniz
dc.contributor.authorAkbas, Tugana
dc.contributor.authorMert, Mustafa Kurthan
dc.contributor.authorSoker, Gokhan
dc.contributor.orcID0000-0002-5505-8707en_US
dc.contributor.pubmedID34763993en_US
dc.date.accessioned2022-11-11T09:15:56Z
dc.date.available2022-11-11T09:15:56Z
dc.date.issued2022
dc.description.abstractBackground: This study examined the effect of corticosteroids on the thymic index (TI) and the thymus/weight index (TWI) in infants exposed to antenatal corticosteroids (ACS). Methods: This prospective study was conducted between August 2014 and October 2018. A thymus ultrasound was performed to assess thymus size on the second day of life. Thymus size was assessed as TI and TWI. Results: In total, 167 neonates (<= 34 weeks gestation) constituted the study population, including 94 ACSexposed infants and 73 untreated infants. The treatment group exhibited significantly lower birth weight and significantly shorter birth length than the ACS (-) group. Therefore, TI was smaller in the treatment group than in the untreated group (6.96 +/- 4.05 cm(3) vs. 5.64 +/- 3.39 cm(3)). The TWI was 3.69 +/- 1.8 cm(3)/kg in the ACS (-) group versus 3.32 +/- 1.56 cm(3)/kg in the ACS (+) group. The median anteroposterior diameter of the right lobe was 1.33 cm (range, 0.45-2.40) in the ACS (-) group compared to 1.15 cm (range, 0.47-2.40) in the ACS (+) group. The median anteroposterior diameter of the left lobe was 1.40 cm (range, 0.43-2.20) in the ACS (-) group and 1.19 cm (range, 0.32-2.36) in the ACS (+) group. The median largest sagittal area was 2.64 cm(2) (range, 0.5-5.46) in the ACS (-) group versus 2.20 cm(2) (range, 0.55-5.90) in the ACS (+) group. Conclusion: We found that TWI was not significantly changed by ACS exposure in premature infants. (C) 2021 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.en_US
dc.identifier.endpage71en_US
dc.identifier.issn0929-693Xen_US
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85118824034en_US
dc.identifier.startpage67en_US
dc.identifier.urihttp://hdl.handle.net/11727/8065
dc.identifier.volume29en_US
dc.identifier.wos000742534300005en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.arcped.2021.09.015en_US
dc.relation.journalARCHIVES DE PEDIATRIEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectThymic indexen_US
dc.subjectThymus/weight indexen_US
dc.subjectThymic sizeen_US
dc.subjectAntenatal corticosteroidsen_US
dc.subjectPreterm infanten_US
dc.titleImpact of antenatal corticosteroid exposure on thymus size in premature infantsen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: